Our analysis demonstrated that the transcriptional program regulated by IL-22 (Mann–Whitney, two-tailed test, P < 0.0001, Fig. 1f) was significantly enriched in UC in comparison with non-IBD control subjects. Here, IL22 is linked to inflammatory bowel disease.